Disease progression in idiopathic pulmonary fibrosis with mild physiological impairment: analysis from the Australian IPF registry

Disease progression in idiopathic pulmonary fibrosis with mild physiological impairment: analysis from the Australian IPF registry

Abstract Background Idiopathic pulmonary fibrosis (IPF) is a progressive and fatal fibrosing lung disease of unknown cause. The advent of anti-fibrotic medications known to slow disease progression has revolutionised IPF management in recent years. However, little is known about the natural history...

Full description

Bibliographic Details
Main Authors: Helen E. Jo, Ian Glaspole, Yuben Moodley, Sally Chapman, Samantha Ellis, Nicole Goh, Peter Hopkins, Greg Keir, Annabelle Mahar, Wendy Cooper, Paul Reynolds, E. Haydn Walters, Christopher Zappala, Christopher Grainge, Heather Allan, Sacha Macansh, Tamera J. Corte
Format: Article
Language:English
Published: BMC 2018-01-01
Series:BMC Pulmonary Medicine
Subjects:
Idiopathic pulmonary fibrosis
Interstitial lung disease
Disease severity
Online Access:http://link.springer.com/article/10.1186/s12890-018-0575-y

Internet

http://link.springer.com/article/10.1186/s12890-018-0575-y

Similar Items